Phase II - III Clinical Trials
Fully configured EDC study databases developed on SCiAN's
EDCPRO platform are available for IND stage
phase II - III clinical studies on a monthly subscription
basis.
EDCPRO is a powerful and effective Web-based clinical
data management system that incorporates SCiAN's 15 years of EDC
knowledge and experience in managing IND-stage clinical
trials. Founded on our therapeutic area expertise, the
intuitive user interface helps Study Coordinators, Monitors,
Project & Data Managers, Medical Monitors and Statisticians
complete their tasks with ease, efficiency and minimum
administrative overhead.
Sponsors can select a fully configured EDC study database from
our extensive library based on patient population, the clinical
phase and the design of the study:
Databases by Indication / Therapeutic Area
- Oncology
- Autoimmune - Inflammatory
- Cardiovascular
- CNS - Neurology - Pain
- Dermatology
- Diabetes - Metabolic
- Gastroenterology
- Infectious diseases
- Respiratory.
Databases by Study
Design1
- Dose-escalation: open-label, single-arm
- Dose-escalation: randomized, placebo-controlled (blinded)
design
- Parallel group randomized (blinded) dose ranging
w/out placebo group
- 2x2 Latin-square and other cross-over designs
- Dose-escalation desigs
- 2-stage phase II designs
- Open label and other parallel group designs
- Adaptive designs
- Multi-stage designs
- Sequential designs.
1) PK, PD and biomarker sub-studies supported